Milou‐Daniel Drici

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Michele Fusaroli, Francesco Salvo, Bernard Bégaud et al. · Drug Safety · 2024 · 213 citations · Full text

Cardiac Actions of Erythromycin

Milou‐Daniel Drici, Björn C. Knollmann, Wen-Xiu Wang et al. · JAMA · 1998 · 192 citations

Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of <i>I_to1</i> in cardiac electrogenesis

Sylvie Diochot, Milou‐Daniel Drici, Danielle Moinier et al. · British Journal of Pharmacology · 1999 · 158 citations · Full text

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

Alexandre O. Gérard, Serena Romani, Audrey Fresse et al. · Therapies · 2020 · 144 citations · Full text

Drug Safety, Drug Interactions, Cardiovascular Toxicity +12

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Michele Fusaroli, Francesco Salvo, Bernard Bégaud et al. · Drug Safety · 2024 · 142 citations · Full text